Anti-VEGF antibody compositions and methods

Details for Australian Patent Application No. 2008324045 (hide)

Owner Peregrine Pharmaceuticals, Inc. Affitech Research AS

Inventors Schlunegger, Kyle; Kavlie, Anita

Agent Davies Collison Cave

Pub. Number AU-A-2008324045

PCT Pub. Number WO2009/060198

Priority 60/987,015 09.11.07 US; 61/106,047 16.10.08 US; 61/108,023 24.10.08 US

Filing date 7 November 2008

Wipo publication date 14 May 2009

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/060198 Priority application(s): WO2009/060198

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324056-Pharmaceutical composition for cancer treatment

2008324033-Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias